Healthcare -
Biotechnology - NASDAQ - FR
$ 2.1264
0.302 %
$ 178 M
Market Cap
-4.83
P/E
IPHA - SHORT-TERM DEBT
Short-term Debt IPHA - Innate Pharma S.A.
8.94 M
LAST VALUE
-46.09%
2 YEAR CAGR
46.00%
5 YEAR CAGR
30.73%
10 YEAR CAGR